Sarah S Seo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Otolaryngology, Lebanon, NH 03756 Phone: 603-650-8123 |
Dr. Glenn Dwight Johnson, M.D. Otolaryngology - Otology & Neurotology Medicare: Not Enrolled in Medicare Practice Location: Dartmouth-hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756 Phone: 603-650-8124 Fax: 603-650-7898 |
Dr. Giridhar Venkatraman, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5174 |
Dr. Benoit J Gosselin, MD, FRCSC Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth-hitchcock Medical Center-otolaryngology, Lebanon, NH 03756 Phone: 603-650-8123 Fax: 603-650-0052 |
Eunice Y Chen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Otolaryngology Section, Dhmc, Lebanon, NH 03756 Phone: 603-650-8122 Fax: 603-650-0052 |
Dr. Mark Christopher Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Otolaryngology, Lebanon, NH 03756 Phone: 603-650-8123 |
James E Saunders, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr., Dhmc Division Of Otolarynoglogy, Lebanon, NH 03756 Phone: 603-650-8123 Fax: 603-650-0052 |
Dr. Sean Robert Wise, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Lebanon, NH 03756 Phone: 603-650-8123 |
Dr. Ryan E Little, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8123 |
Dr. Richard B Smith Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Otolaryngology, Lebanon, NH 03756 Phone: 603-650-9762 |
Dr. Joseph A Paydarfar, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Division Of Otolaryngology, Lebanon, NH 03756 Phone: 603-650-8112 Fax: 603-650-7898 |
Dr. James Oliver Donegan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dartmouth-hitch Clinic, Lebanon, NH 03756 Phone: 603-650-8123 Fax: 603-650-7898 |
News Archive
In perfecting the science of medicine, advancements always face exhaustive scrutiny and opposition. Typically, these rigors focus on confirming the efficacy of a procedure or treatment to ensure it remains in the patient's best interest for healing or wellness. More recently, with heightened emphasis on government-funded healthcare, medical procedures such as robotic prostatectomy surgery for prostate cancer treatment are under fire for cost.
Clues about how a suspect version of a gene may slightly increase risk for schizophrenia are emerging from a brain imaging study by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH). The gene variant produced a telltale pattern of activity linked to production of a key brain messenger chemical.
Cells that express neurogenin 3 (NGN3) may one day be harnessed to create a plentiful supply of insulin-producing beta cells for the treatment of diabetes, a study led by researchers at the University of South Florida suggests.
A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine-, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital of Cook County, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery.
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
› Verified 1 days ago